Abstract
Type I pseudohypoaldosteronism (PHA) is a hereditary syndrome of salt wasting resulting from unresponsiveness to mineralocorticoids. PHA is manifested in two clinically and genetically distinct forms, affecting either only the kidney or multiple target organs of aldosterone. We examined the mineralocorticoid effect of carbenoxolone (CBX) in young PHA patients with either renal or multisystem resistance to aldosterone to find out whether CBX may help reduce the requirement for a high-salt diet. CBX did not show any significant salt-retaining effect in two patients with multiple PHA, and did not affect the renin-aldosterone system. In contrast, CBX significantly suppressed the renin-aldosterone system in a renal PHA patient for the whole duration of treatment, but without a long-term salt-retaining effect. On CBX treatment, urinary cortisone levels decreased and the cortisol:cortisone ratio increased, indicating that CBX inhibited 11beta-HSD activity that metabolizes cortisol to cortisone. The complete lack of effect of CBX on the renin-aldosterone system in multisystem PHA patients indicates that CBX does not exert an effect via mineralocorticoid (MR) or glucocorticoid receptors. Examination of the structure and expression of th...Continue Reading
References
Feb 1, 1979·The Journal of Clinical Endocrinology and Metabolism·S E OberfieldM I New
Aug 1, 1992·Kidney International·C P Bastl, J P Hayslett
Jan 1, 1991·The Journal of Steroid Biochemistry and Molecular Biology·D ArmaniniU Kuhnle
Nov 1, 1991·The Journal of Clinical Endocrinology and Metabolism·A Hanukoglu
Mar 1, 1991·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·R J HoggJ C Frolich
Oct 10, 1987·Lancet·P M StewartC R Edwards
Oct 29, 1988·Lancet·C R EdwardsC Monder
Jul 17, 1987·Science·J L ArrizaR M Evans
Nov 1, 1988·Analytical Biochemistry·T A CiullaS L Hauser
Jan 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·G Miller, M Lipman
Dec 1, 1974·The Journal of Clinical Endocrinology and Metabolism·M C Postel-VinayP Royer
Sep 1, 1995·Nature Genetics·J H HanssonR P Lifton
Sep 1, 1994·Current Opinion in Nephrology and Hypertension·B C RossierJ D Horisberger
Dec 1, 1994·The Journal of Steroid Biochemistry and Molecular Biology·U KuhnleZ Krozowski
Nov 1, 1994·The Journal of Pediatrics·A HanukogluA Mandelberg
Jul 28, 1994·The New England Journal of Medicine·P C White
Mar 1, 1996·Nature Genetics·S S ChangR P Lifton
Feb 1, 1996·Human Molecular Genetics·S S StrautnieksE Chung
Citations
Sep 12, 2000·Current Hypertension Reports·D G Warnock
May 19, 2001·The Journal of Steroid Biochemistry and Molecular Biology·A HanukogluM Phillip
Apr 14, 2006·Journal of the American Society of Nephrology : JASN·David S GellerRichard P Lifton
Apr 10, 2004·Medical Law International·O Anson
May 31, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Wei-Ren LanHung-I Yeh